I"><h1 id="recruitment">Recruitment</h1>
<p>Subjects will be recruited via a variety of means, including posted notices on- and off-campus, Penn’s SBSI platform, announcements on the lab website, social media (Twitter, Facebook, Instagram), online electronic newsgroups, text/email/phone or newspaper advertisements,  CHOP/Penn medical record review and through the Brain Behavior Lab’s registry of previous research participants who have consented to be re-contacted about participating in future research, or by clinician referral from physicians within the Penn Medicine/CHOP system. 
Target: 2000 participants along with parents of minor participants to participate in virtual procedures. Of these, 500 participants will be asked to come in for non-contrast agent MRI procedures.</p>

<p><em>Key Inclusion Criteria</em>:</p>
<ul>
  <li>Age: 13-25.</li>
  <li>Sex: Males and Females</li>
  <li>Proficiency in English
    <ul>
      <li>Mood and anxiety group: Mood and anxiety group must demonstrate evidence of a mood or anxiety disorder (All ICD codes encompassed by mood/anxiety disorders in DSM (excluding Bipolar Disorder I &amp; II), Borderline personality disorder, Clinically significant affective instability from clinician referrals, Treatment with a SSRI, Elevated PHQ-9 scores administered during standard health system screening.)</li>
      <li>Typically Developing Group: No current or documented history DSM IV axis I or II diagnosis, or use of psychoactive medications.</li>
    </ul>
  </li>
</ul>

<p><em>Key Exclusion Criteria</em>:</p>
<ul>
  <li>Significant medical or neurological illness that may increase risk.</li>
  <li>Pregnancy</li>
  <li>Any history of pervasive developmental disorder or intellectual disability</li>
  <li>Documented history of a psychotic disorder, bipolar disorder, or clinically significant current substance misuse</li>
  <li>Non-psychiatric medical disorders that may impact brain function or visual acuity</li>
  <li>Lack of a mobile device with capabilities to complete study procedures</li>
  <li>Acute intoxication with alcohol or other substances based on clinical assessment, subject report, or results of laboratory testing</li>
  <li>For 3T and 7T participants only: contraindications/claustrophobia</li>
</ul>

<h1 id="procedure">Procedure</h1>
<ul>
  <li>Participants will perform self-report questionnaires, a neurocognitive battery assessment and both passive and active mobile data collection on the custom-built AWARE App.</li>
  <li>After consent, participants will be asked to complete a neurocognitive battery online, as well as self-report questionnaires and a computerized adaptive clinical interview.</li>
  <li>Participants will also be directed to download the AWARE app. There will be 2, 2-week periods of active survey collection 3 times per day, and passive data collection using the AWARE app for 6 months. EMA questions from the app will include questions related to mood, behavior, sleep, or other aspects pertaining to participants’ daily lives.</li>
  <li>In addition to survey data, AWARE will passively collect information pertaining to accelerometer data, GPS data, phone call and text messaging meta-data, all key-stroke data (with the exception of passwords), and phone/screen usage data.</li>
  <li>A subsample of (500) participants will be brought in for imaging procedures.  Imaging visits will last approximately 2-3  hours and will be conducted at Penn/CHOP.</li>
</ul>

<h1 id="compensation">Compensation</h1>
<p><em>Participants will be reimbursed for travel (transportation and parking) expenses incurred on scan day.</em>
<em>All participants will be paid virtually using Venmo or PayPal applications.</em></p>
<ul>
  <li>Payment for virtual participation:
    <ul>
      <li>AWARE surveys:Subjects will receive $1 per survey they complete during each of the 2 weeks, with a $3 bonus for completing more than 75% of the surveys (up to $24/week.) Subjects will be paid $3 for each month of passive data collection (detailed below) for 6 months (up to $18).</li>
      <li>Computerized Neurocognitive Battery (1 hour): Subjects performing cognitive testing with the standard Computerized Neurocognitive Battery (CNB) applied routinely in the Brain Behavior Laboratory will be paid $20.</li>
      <li>Self-Report Measures: (1 hour): Subjects will be compensated $10 for completion of proposed surveys assessments.</li>
      <li><strong>Total compensation possible: $144 over 6 months</strong></li>
    </ul>
  </li>
  <li>Assessments of Decision-making, Reward, Motivation, and Sociability  (1 hour): $40</li>
  <li>Magnetic Resonance Imaging (1 hour): $60</li>
</ul>
:ET